Skip to main content
logo
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.7822
-0.0098 (-1.24%)
At close: Oct 9, 2026, 4:00 PM EDT
0.7704
-0.0118 (-1.51%)
After-hours: Oct 9, 2026, 7:49 PM EDT

LABT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
2.580.240.682.53
Short-Term Investments
2--3.86
Cash & Short-Term Investments
4.580.240.686.39
Cash Growth
261.45%-65.29%-89.34%-
Prepaid Expenses
0.260.070.090.09
Total Current Assets
4.850.310.776.48
Property, Plant & Equipment
0.110.170.290.4
Other Long-Term Assets
0.010.010.010.01
Total Assets
4.960.481.076.89

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Payable
0.170.380.170.5
Accrued Expenses
0.360.40.221.26
Short-Term Debt
-1.5-0.2
Current Portion of Leases
0.10.120.110.11
Total Current Liabilities
0.632.410.52.06
Long-Term Leases
-0.040.160.27
Total Liabilities
0.632.450.662.34

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Common Stock
0000
Additional Paid-In Capital
73.1251.5350.0649.3
Retained Earnings
-68.64-53.35-49.5-44.65
Treasury Stock
-0.15-0.15-0.15-0.1
Total Common Equity
4.33-1.970.414.56
Shareholders' Equity
4.33-1.960.414.56
Total Liabilities & Equity
4.960.481.076.89

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Total Debt
0.11.660.270.58
Net Cash (Debt)
4.48-1.420.415.81
Net Cash Growth
---92.97%-
Net Cash Per Share
5.10-2.050.598.53
Filing Date Shares Outstanding
2.370.70.690.68
Total Common Shares Outstanding
2.170.70.690.68
Working Capital
4.22-2.10.274.42
Book Value Per Share
2.00-2.810.596.69
Tangible Book Value
4.33-1.970.414.56
Tangible Book Value Per Share
2.00-2.810.596.69
Machinery
-0.080.080.08
SEC Filings: 10-K · 10-Q